<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: AKAP12/Gravin (A kinase anchor protein 12) is one of the A-kinase scaffold proteins and a potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in human primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Our recent study demonstrated the highly recurrent loss of AKAP12 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and AKAP12 reexpression inhibited proliferation and anchorage-independent growth in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, implicating AKAP12 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> pathogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: To evaluate the effect of this gene on the progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, we examined the impact of overexpressing AKAP12 in the AKAP12-negative human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line LoVo, the single clone (LoVo-AKAP12) compared to mock-transfected cells (LoVo-CON) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: pCMV6-AKAP12-mediated AKAP12 re-expression induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (3% to 12.7%, p&lt;0.01), migration (89.6±7.5 cells to 31.0±4.1 cells, p&lt;0.01) and invasion (82.7±5.2 cells to 24.7±3.3 cells, p&lt;0.01) of LoVo cells in vitro compared to control cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0003815'>Nude</z:mp> mice injected with LoVo-AKAP12 cells had both significantly reduced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> volume (p&lt;0.01) and <z:mp ids='MP_0006042'>increased apoptosis</z:mp> compared to mice given AKAP12-CON </plain></SENT>
<SENT sid="5" pm="."><plain>The quantitative human-specific Alu PCR analysis showed overexpression of AKAP12 suppressed the number of intravasated cells in vivo (p&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: These results demonstrate that AKAP12 may play an important role in <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> suppression and the survival of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>